174 related articles for article (PubMed ID: 36376850)
1. Identification of a novel miRNA-based recurrence and prognosis prediction biomarker for hepatocellular carcinoma.
Zhang X; Zhang D; Bu X; Zhang X; Cui L
BMC Bioinformatics; 2022 Nov; 23(1):479. PubMed ID: 36376850
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
3. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y
J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion.
Chen W; Wang H; Li T; Liu T; Yang W; Jin A; Ding L; Zhang C; Pan B; Guo W; Wang B
BMC Med Genomics; 2022 Feb; 15(1):34. PubMed ID: 35197055
[TBL] [Abstract][Full Text] [Related]
6. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
Song SK; Jung WY; Park SK; Chung CW; Park Y
PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
[TBL] [Abstract][Full Text] [Related]
7. The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma Diagnosis.
Shi Y; Men J; Sun H; Tan J
Med Chem; 2022; 18(10):1073-1085. PubMed ID: 35379158
[TBL] [Abstract][Full Text] [Related]
8. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.
Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY
Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974
[TBL] [Abstract][Full Text] [Related]
9. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J
PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238
[TBL] [Abstract][Full Text] [Related]
10. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
11. Identification and analysis of circRNA-miRNA-mRNA regulatory network in hepatocellular carcinoma.
Zhou D; Dong L; Yang L; Ma Q; Liu F; Li Y; Xiong S
IET Syst Biol; 2020 Dec; 14(6):391-398. PubMed ID: 33399102
[TBL] [Abstract][Full Text] [Related]
12. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
Chen S; Zhang Y; Ding X; Li W
Front Genet; 2022; 13():838869. PubMed ID: 35386284
[No Abstract] [Full Text] [Related]
13. Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma.
Long HD; Ma YS; Yang HQ; Xue SB; Liu JB; Yu F; Lv ZW; Li JY; Xie RT; Chang ZY; Lu GX; Xie WT; Fu D; Pang LJ
Mol Biol Rep; 2018 Dec; 45(6):2615-2623. PubMed ID: 30341691
[TBL] [Abstract][Full Text] [Related]
14. [Identification of onco-miRNAs in hepatocellular carcinoma and analysis of their regulatory network].
Ye J; Xu W; Chen T
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):45-54. PubMed ID: 35249869
[TBL] [Abstract][Full Text] [Related]
15. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
Zheng L; Wang J; Jiang H; Dong H
Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
17. Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma.
Eun JW; Ahn HR; Baek GO; Yoon MG; Son JA; Weon JH; Yoon JH; Kim HS; Han JE; Kim SS; Cheong JY; Kim BW; Cho HJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901700
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma.
Qin L; Huang J; Wang G; Huang J; Wu X; Li J; Yi W; Qin F; Huang D
J Cell Physiol; 2019 Dec; 234(12):23581-23595. PubMed ID: 31210353
[TBL] [Abstract][Full Text] [Related]
19. Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis.
Morovat P; Morovat S; Ashrafi AM; Teimourian S
Sci Rep; 2022 Mar; 12(1):4933. PubMed ID: 35322101
[TBL] [Abstract][Full Text] [Related]
20. Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis.
Sun X; Ge X; Xu Z; Chen D
J Gastroenterol Hepatol; 2020 Jan; 35(1):157-164. PubMed ID: 31222831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
